Back to Search Start Over

Neuroprotective effect of long-term NDI1 gene expression in a chronic mouse model of Parkinson disorder.

Authors :
Barber-Singh J
Seo BB
Nakamaru-Ogiso E
Lau YS
Matsuno-Yagi A
Yagi T
Barber-Singh, Jennifer
Seo, Byoung Boo
Nakamaru-Ogiso, Eiko
Lau, Yuen-Sum
Matsuno-Yagi, Akemi
Yagi, Takao
Source :
Rejuvenation Research. Aug2009, Vol. 12 Issue 4, p259-267. 9p.
Publication Year :
2009

Abstract

Previously, we showed that the internal rotenone-insensitive nicotinamide adenine dinucleotide (NADH)-quinone oxidoreductase (NDI1) gene from Saccharomyces cerevisiae (baker's yeast) can be successfully inserted into the mitochondria of mice and rats and the expressed enzyme was found to be fully functional. In this study, we investigated the ability of the Ndi1 enzyme to protect the dopaminergic neurons in a chronic mouse model of Parkinson disorder. After expression of the NDI1 gene in the unilateral substantia nigra of male C57BL/6 mice for 8 months, a chronic Parkinsonian model was created by administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) with probenecid and evaluated using neurochemical and behavioral responses 1-4 weeks post-MPTP/probenecid injection. We showed that expression of Ndi1 was able to significantly prevent the loss of dopamine and tyrosine hydroxylase as well as the dopaminergic transporters in the striatum of the chronic Parkinsonian mice. Behavioral assessment based on a methamphetamine-induced rotation test and spontaneous swing test further supported neurological preservation in the NDI1-treated Parkinsonian mice. The data presented in this study demonstrate a protective effect of the NDI1 gene in dopaminergic neurons, suggesting its therapeutic potential for Parkinson-like disorders. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
15491684
Volume :
12
Issue :
4
Database :
Academic Search Index
Journal :
Rejuvenation Research
Publication Type :
Academic Journal
Accession number :
105230838
Full Text :
https://doi.org/10.1089/rej.2009.0854